These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 3425862
21. Azelastine reduces allergen-induced nasal response: a clinical and rhinomanometric assessment. Lurie A, Saudubray F, Eychenne JL, Venot A, de Lauture D, Dessanges JF, Lockhart A, Strauch G. Eur J Clin Pharmacol; 1992; 42(2):213-6. PubMed ID: 1352247 [Abstract] [Full Text] [Related]
22. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Pullerits T, Praks L, Skoogh BE, Ani R, Lötvall J. Am J Respir Crit Care Med; 1999 Jun; 159(6):1814-8. PubMed ID: 10351924 [Abstract] [Full Text] [Related]
23. Nasal and bronchial response to exercise in children with seasonal allergic rhinitis out of the pollen season. Harmancı K, Urhan B, Anıl H, Kocak A. Int Forum Allergy Rhinol; 2015 Feb; 5(2):143-8. PubMed ID: 25504747 [Abstract] [Full Text] [Related]
24. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E. Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338 [Abstract] [Full Text] [Related]
25. Decongestion test in patients with allergic rhinitis: functional evaluation of nasal airflow. Ciprandi G, Cirillo I, Vizzaccaro A, Pallestrini E, Tosca MA. Am J Rhinol; 2006 Jun; 20(2):224-6. PubMed ID: 16686394 [Abstract] [Full Text] [Related]
26. The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Collins LP, Hunter MG, Steiner J, Lewis T, Payton MA, Perkins CM, Pettipher R. Allergy; 2012 Dec; 67(12):1572-9. PubMed ID: 23025511 [Abstract] [Full Text] [Related]
27. [Evaluation of the efficacy of the magnesium salt of N-acetyl-aspartyl-glutamic acid in the treatment of acute rhinitis]. Miadonna A, Tedeschi A, Parravicini P, Lorini M. Clin Ter; 1989 Nov 15; 131(3):173-6. PubMed ID: 2575479 [Abstract] [Full Text] [Related]
28. Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting. Berkowitz RB, Roberson S, Zora J, Capano D, Chen R, Lutz C, Harris AG. Allergy Asthma Proc; 1999 Nov 15; 20(3):167-72. PubMed ID: 10389549 [Abstract] [Full Text] [Related]
29. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber. Kyrein HJ, Horak F, Nirnberger G, Rehn D. Arzneimittelforschung; 1996 Aug 15; 46(8):794-9. PubMed ID: 9125281 [Abstract] [Full Text] [Related]
30. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Bonay M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, Aubier M. Allergy; 2006 Jan 15; 61(1):111-8. PubMed ID: 16364165 [Abstract] [Full Text] [Related]
31. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. Zenner HP, Baumgarten C, Rasp G, Fuchs T, Kunkel G, Hauswald B, Ring J, Effendy I, Behrendt W, Frosch PJ, Przybilla B, Brunner FX, Merk HF, Kapp A, Schnitker J, Wolf H. J Allergy Clin Immunol; 1997 Jul 15; 100(1):23-9. PubMed ID: 9257783 [Abstract] [Full Text] [Related]
32. The effect of a new anti-allergic drug ICI 74, 9I7, given by aerosol, on nasal stenosis induced by allergen. Vilsvik JS, Jenssen AO. Clin Allergy; 1976 Sep 15; 6(5):487-91. PubMed ID: 975489 [Abstract] [Full Text] [Related]
33. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis. Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A. Ann Allergy Asthma Immunol; 2004 Apr 15; 92(4):438-45. PubMed ID: 15104196 [Abstract] [Full Text] [Related]
34. [Effectiveness and tolerance of the C3 convertase inhibitor, N-acetyl-aspartyl-magnesium glutamate with anti-allergic action. Results of a double-blind study]. Gastpar H, Kiehn R, Sieger C, Weibel MA. Arzneimittelforschung; 1989 Feb 15; 39(2):270-2. PubMed ID: 2659002 [Abstract] [Full Text] [Related]
35. Canine model of nasal congestion and allergic rhinitis. Tiniakov RL, Tiniakova OP, McLeod RL, Hey JA, Yeates DB. J Appl Physiol (1985); 2003 May 15; 94(5):1821-8. PubMed ID: 12547842 [Abstract] [Full Text] [Related]
36. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge. Erin EM, Leaker BR, Zacharasiewicz AS, Higgins LA, Williams TJ, Boyce MJ, de Boer P, Durham SR, Barnes PJ, Hansel TT. Allergy; 2005 Dec 15; 60(12):1524-9. PubMed ID: 16266385 [Abstract] [Full Text] [Related]
37. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U. Curr Med Res Opin; 2006 Jan 15; 22(1):151-7. PubMed ID: 16393441 [Abstract] [Full Text] [Related]
38. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May 15; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
39. A double-blind, placebo-controlled study of the effect of intranasal budesonide in the treatment of children with seasonal rhinitis. Wolthers OD, Jørgensen BA, Pedersen S. Acta Paediatr; 1992 Nov 15; 81(11):902-6. PubMed ID: 1467613 [Abstract] [Full Text] [Related]
40. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis. Holmberg K, Pipkorn U, Bake B, Blychert LO. Allergy; 1989 May 15; 44(4):281-7. PubMed ID: 2567579 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]